Perhaps stating the obvious, this website is currently a work in progress. We will continue to add articles to this site as we get permission to and confirmation that some of our restricted material is okay to post or transcribe from our sources.

If time permits, we will also try and translate as much of our English language material into German and vice versa. We consider the German and Swiss mid-cap and small-cap drug development space to be a relatively under-researched niche.

All articles are the opinions of the fine folks at Biotech Speculators and if you have an article idea or comment then please feel free to email us at tips@biotechspeculators.com